Other Species / Isoforms
  GGTL3 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S8-p
MAAENEAsQEsALGA
0 1
GGTL3 (human) MAAENEAsQEsALGA S8-p
GGTL3 iso5 (human) MAAENEASQESALGA S8
GGTL3 (mouse) MAAENEASQESALGA S8
GGTL3 (rat) MAAENEASQESALGA S8
S11-p
ENEAsQEsALGAYSP
0 1
GGTL3 (human) ENEAsQEsALGAYSP S11-p
GGTL3 iso5 (human) ENEASQESALGAYSP S11
GGTL3 (mouse) ENEASQESALGAYsP S11
GGTL3 (rat) ENEASQESALGAYsP S11
S17
EsALGAYSPVDyMSI
0 3
GGTL3 (human) EsALGAYSPVDyMSI S17
GGTL3 iso5 (human) ESALGAYSPVDYMSI S17
GGTL3 (mouse) ESALGAYsPVDYMSI S17-p
GGTL3 (rat) ESALGAYsPVDYMSI S17-p
Y21-p
GAYSPVDyMSITSFP
0 1
GGTL3 (human) GAYSPVDyMSITSFP Y21-p
GGTL3 iso5 (human) GAYSPVDYMSITSFP Y21
GGTL3 (mouse) GAYsPVDYMSITSFP Y21
GGTL3 (rat) GAYsPVDYMSITSFP Y21
K45-ub
AAPLRGRkDEDAFLG
0 2
GGTL3 (human) AAPLRGRkDEDAFLG K45-ub
GGTL3 iso5 (human) AAPLRGRKDEDAFLG K45
GGTL3 (mouse) AAPLRGRkDEDAFLG K45-ub
GGTL3 (rat) AAPLRGRKDEDAFLG K45
T56-p
AFLGDPDtDPDsFLk
0 7
GGTL3 (human) AFLGDPDtDPDsFLk T56-p
GGTL3 iso5 (human) AFLGDPDTDPDSFLK T56
GGTL3 (mouse) AFLGDPDtDPDsFLk T56-p
GGTL3 (rat) AFLGDPDTDPDSFLK T56
S60-p
DPDtDPDsFLksARL
0 3
GGTL3 (human) DPDtDPDsFLksARL S60-p
GGTL3 iso5 (human) DPDTDPDSFLKSARL S60
GGTL3 (mouse) DPDtDPDsFLkSARL S60-p
GGTL3 (rat) DPDTDPDSFLKSARL S60
K63-ub
tDPDsFLksARLQRL
0 2
GGTL3 (human) tDPDsFLksARLQRL K63-ub
GGTL3 iso5 (human) TDPDSFLKSARLQRL K63
GGTL3 (mouse) tDPDsFLkSARLQRL K63-ub
GGTL3 (rat) TDPDSFLKSARLQRL K63
S64-p
DPDsFLksARLQRLP
0 1
GGTL3 (human) DPDsFLksARLQRLP S64-p
GGTL3 iso5 (human) DPDSFLKSARLQRLP S64
GGTL3 (mouse) DPDsFLkSARLQRLP S64
GGTL3 (rat) DPDSFLKSARLQRLP S64
S72-p
ARLQRLPssssEMGs
Upstream
0 311
Treatment
  • gefitinib
  • LPA
  • selumetinib
  • U0126
  • vemurafenib
view more >
GGTL3 (human) ARLQRLPssssEMGs S72-p
GGTL3 iso5 (human) ARLQRLPSSSSEMGS S72
GGTL3 (mouse) ARLQRLPssssEMGs S72-p
GGTL3 (rat) ARLQRLPSSSSEMGs S72
S73-p
RLQRLPssssEMGsQ
0 31
GGTL3 (human) RLQRLPssssEMGsQ S73-p
GGTL3 iso5 (human) RLQRLPSSSSEMGSQ S73
GGTL3 (mouse) RLQRLPssssEMGsQ S73-p
GGTL3 (rat) RLQRLPSSSSEMGsQ S73
S74-p
LQRLPssssEMGsQD
0 28
GGTL3 (human) LQRLPssssEMGsQD S74-p
GGTL3 iso5 (human) LQRLPSSSSEMGSQD S74
GGTL3 (mouse) LQRLPssssEMGsQD S74-p
GGTL3 (rat) LQRLPSSSSEMGsQD S74
S75-p
QRLPssssEMGsQDG
Upstream
0 41
Treatment
  • gefitinib
GGTL3 (human) QRLPssssEMGsQDG S75-p
GGTL3 iso5 (human) QRLPSSSSEMGSQDG S75
GGTL3 (mouse) QRLPssssEMGsQDG S75-p
GGTL3 (rat) QRLPSSSSEMGsQDG S75
S79-p
ssssEMGsQDGsPLR
Upstream
0 20
Treatment
  • selumetinib
  • vemurafenib
GGTL3 (human) ssssEMGsQDGsPLR S79-p
GGTL3 iso5 (human) SSSSEMGSQDGSPLR S79
GGTL3 (mouse) ssssEMGsQDGsPLR S79-p
GGTL3 (rat) SSSSEMGsQDGsPLR S79-p
S83-p
EMGsQDGsPLREtRK
Upstream
0 49
Treatment
  • selumetinib
  • vemurafenib
GGTL3 (human) EMGsQDGsPLREtRK S83-p
GGTL3 iso5 (human) EMGSQDGSPLRETRK S83
GGTL3 (mouse) EMGsQDGsPLRETRK S83-p
GGTL3 (rat) EMGsQDGsPLRETRK S83-p
T88-p
DGsPLREtRKDPFSA
0 1
GGTL3 (human) DGsPLREtRKDPFSA T88-p
GGTL3 iso5 (human) DGSPLRETRKDPFSA T88
GGTL3 (mouse) DGsPLRETRKDPFSA T88
GGTL3 (rat) DGsPLRETRKDPFSA T88
N198
LVHDIRRNESHLIDF
0 1
GGTL3 (human) LVHDIRRNESHLIDF N198
GGTL3 iso5 (human) LVHDIRRNESHLIDF N198
GGTL3 (mouse) LVHDIRRnESHLIDF N198-ng
GGTL3 (rat) LVHDIRRNESHLIDF N198
K225-ub
LQRSWETkPGLLVGV
0 1
GGTL3 (human) LQRSWETkPGLLVGV K225-ub
GGTL3 iso5 (human) LQRSWETKVGTLVRR K225
GGTL3 (mouse) LQRSWDTKPGLLVGV K225
GGTL3 (rat) LQRSWDTKPGLLVGV K225
N283
LAEQLPPNMSERFRE
0 1
GGTL3 (human) LAEQLPPNMSERFRE N283
GGTL3 iso5 (human) gap -
GGTL3 (mouse) LAEQLPPnASDRFLD N283-ng
GGTL3 (rat) LAEQLPPNASDRFLE N283
N394
LNILEGFNLTSLVSR
0 1
GGTL3 (human) LNILEGFNLTSLVSR N394
GGTL3 iso5 (human) gap -
GGTL3 (mouse) LNILEGFnLTSLVSR N394-ng
GGTL3 (rat) LNILEGFNLTSLVSR N394
S434
YDSTITESMDDMLSK
0 1
GGTL3 (human) YDSTITESMDDMLSK S434
GGTL3 iso5 (human) gap -
GGTL3 (mouse) YDSTITEsMDDMLSK S434-p
GGTL3 (rat) YDSTISESMDDMLSK S434
N523
SWPNRTANHSAPSLE
0 1
GGTL3 (human) SWPNRTANHSAPSLE N523
GGTL3 iso5 (human) gap -
GGTL3 (mouse) SWPNRTAnHSAPSLE N523-ng
GGTL3 (rat) SWPNRTANHSAPSLE N523
N586
NVLTLNRNLSDSLAR
0 1
GGTL3 (human) NVLTLNRNLSDSLAR N586
GGTL3 iso5 (human) gap -
GGTL3 (mouse) NVLTLNRnLSDSLAR N586-ng
GGTL3 (rat) NVLTLNRNLSDSLAR N586
T660
SPDAAGATIL_____
0 1
GGTL3 (human) SPDAAGATIL_____ T660
GGTL3 iso5 (human) gap -
GGTL3 (mouse) SPDAAGAtIL_____ T660-p
GGTL3 (rat) SLDATGASIL_____ S660